WO2004111029A2
(en)
*
|
2003-06-10 |
2004-12-23 |
Teva Pharmaceutical Industries Ltd. |
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
|
US7601737B2
(en)
*
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
US7863274B2
(en)
*
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
BRPI0615973A2
(pt)
*
|
2005-07-29 |
2011-05-31 |
Concert Pharmaceuticals Inc |
novos derivados de benzo [d] [1,3] - dioxol
|
US20100076087A1
(en)
*
|
2005-10-06 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Methods of reduction of interpatient variability
|
CA2624179A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
|
EP2194039A1
(en)
*
|
2006-03-16 |
2010-06-09 |
Vertex Pharmceuticals Incorporated |
Process for preparing optically enriched compounds
|
AU2007267612A1
(en)
*
|
2006-05-26 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted carboxylic acid compounds
|
CN101594870A
(zh)
*
|
2006-08-22 |
2009-12-02 |
康塞特医药品有限公司 |
4-氨基喹唑啉衍生物及其使用方法
|
US20110053964A1
(en)
*
|
2006-08-22 |
2011-03-03 |
Roger Tung |
4-aminoquinazoline derivatives and methods of use thereof
|
US20080280927A1
(en)
*
|
2006-10-20 |
2008-11-13 |
Concert Pharmaceuticals Inc. |
3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
|
WO2008070313A2
(en)
*
|
2006-10-20 |
2008-06-12 |
Concert Pharmaceuticals Inc. |
3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
|
US20090270425A1
(en)
*
|
2006-10-20 |
2009-10-29 |
Concert Pharmaceuticals Inc. |
3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
|
US20090197899A1
(en)
*
|
2006-10-20 |
2009-08-06 |
Concert Pharmaceuticals Inc. |
3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use
|
WO2008066620A2
(en)
*
|
2006-10-20 |
2008-06-05 |
Concert Pharmaceuticals Inc. |
Dibenzothiazepine derivatives
|
JP5302200B2
(ja)
*
|
2006-10-23 |
2013-10-02 |
コンサート ファーマシューティカルズ インコーポレイテッド |
オキサゾリジノン誘導体および使用方法
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
WO2008063600A2
(en)
*
|
2006-11-17 |
2008-05-29 |
Concert Pharmaceuticals Inc. |
Triazolyl tropane derivatives
|
US20100260674A1
(en)
*
|
2006-12-15 |
2010-10-14 |
Concert Pharmaceuticals, Inc. |
Quinazoline derivatives and methods of treatment
|
US8343950B2
(en)
*
|
2006-12-15 |
2013-01-01 |
Concert Pharmaceuticals, Inc. |
Quinazoline derivatives and methods of treatment
|
US20090325976A1
(en)
*
|
2006-12-21 |
2009-12-31 |
Concert Pharmaceuticals Inc. |
Prostacyclin derivatives
|
WO2008088727A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
US8080549B2
(en)
*
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
WO2008097468A2
(en)
*
|
2007-02-02 |
2008-08-14 |
Concert Pharmaceuticals, Inc. |
Selective endothelin type-a antagonists
|
US20100076010A1
(en)
*
|
2007-02-26 |
2010-03-25 |
Concert Pharmaceuticals, Inc. |
Alpha 1a-adrenoceptor antagonists
|
WO2008106125A2
(en)
*
|
2007-02-26 |
2008-09-04 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
|
ATE509015T1
(de)
*
|
2007-03-07 |
2011-05-15 |
Concert Pharmaceuticals Inc |
Deuterierte piperazinderivate als verbindungen gegen angina
|
ES2559838T3
(es)
*
|
2007-03-16 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Inhibidores de proteína de transferencia de ésteres de colesterol
|
WO2008130863A2
(en)
*
|
2007-04-11 |
2008-10-30 |
Auspex Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
WO2008127640A2
(en)
*
|
2007-04-11 |
2008-10-23 |
Auspex Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
US8198305B2
(en)
*
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
EP2527336A1
(en)
|
2007-04-25 |
2012-11-28 |
Concert Pharmaceuticals Inc. |
Deuterated analogues of cilostazol
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
PT3825306T
(pt)
|
2007-05-01 |
2023-07-24 |
Sun Pharmaceutical Ind Inc |
Compostos de morfinano
|
US7608737B2
(en)
*
|
2007-05-01 |
2009-10-27 |
Concert Pharmaceuticasl Inc. |
Naphthyl(ethyl)acetamides
|
DK2345653T3
(da)
*
|
2007-05-01 |
2013-04-08 |
Concert Pharmaceuticals Inc |
Morphinanforbindelser
|
US7820666B2
(en)
*
|
2007-05-08 |
2010-10-26 |
Concert Pharmaceuticals, Inc. |
Tetrahydrotriazolopyrazine derivatives and uses thereof
|
US20080306151A1
(en)
*
|
2007-06-11 |
2008-12-11 |
Protia, Llc |
Deuterium-enriched fenofibrate
|
WO2008156632A1
(en)
*
|
2007-06-12 |
2008-12-24 |
Concert Pharmaceuticals, Inc. |
Azapeptide derivatives
|
CA2690379A1
(en)
*
|
2007-06-13 |
2008-12-24 |
Auspex Pharmaceuticals, Inc. |
Substituted piperazines
|
US20080318920A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched ezetimibe
|
US20090005366A1
(en)
*
|
2007-06-19 |
2009-01-01 |
Protia, Llc |
Deuterium-enriched olanzapine
|
US7915309B2
(en)
*
|
2007-06-20 |
2011-03-29 |
Protia, Llc |
Deuterium-enriched oseltamivir
|
US20080319007A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched montelukast
|
CA2702317A1
(en)
*
|
2007-07-09 |
2009-01-15 |
Concert Pharmaceuticals, Inc. |
Novel pyrimidinecarboxamide derivatives
|
ES2425183T3
(es)
|
2007-08-14 |
2013-10-11 |
Concert Pharmaceuticals Inc. |
Derivados de oxazolidinonas sustituidas
|
US20090062305A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched cetirizine
|
US20090062299A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched doxazosin
|
US20090062385A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched fesoterodine
|
US20090062561A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched latanoprost
|
US20090062316A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched pelitrexol
|
US20090062374A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched lasofoxifene
|
US20090062393A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched pregabalin
|
US20090062399A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched sertraline
|
US20090062283A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched linezolid
|
US20090069413A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched olopatadine
|
US20090069410A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched paclitaxel
|
WO2009035598A1
(en)
*
|
2007-09-10 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Deuterated pirfenidone
|
US20090069339A1
(en)
*
|
2007-09-11 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched ciprofloxacin
|
AU2008299931B2
(en)
*
|
2007-09-12 |
2013-01-10 |
Concert Pharmaceuticals, Inc. |
Deuterated 4 -oxoquinoline derivatives for the treatment of HIV infection
|
US8288414B2
(en)
*
|
2007-09-12 |
2012-10-16 |
Deuteria Pharmaceuticals, Inc. |
Deuterium-enriched lenalidomide
|
US20090076165A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched memantine
|
US20090069431A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched milnacipran
|
US20090076116A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched carvediolo
|
US20090076010A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched lamotrigine
|
US20090076118A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched saxagliptin
|
US20090075965A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched amoxicilin
|
US20090076112A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched eltrombopag
|
US7919516B2
(en)
*
|
2007-09-13 |
2011-04-05 |
Protia, Llc |
Deuterium-enriched ondansetron
|
US20090076161A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bupropion
|
CA2698808A1
(en)
|
2007-09-13 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
|
US20090076038A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched entecavir
|
US20090076039A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched valacyclovir
|
US20090076034A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bms-690514
|
US20090075991A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched efavirenz
|
US20090075994A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched radafaxine
|
US20090076148A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched pravastatin
|
US20090076102A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched muraglitazar
|
US20090076163A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched dapoxetine
|
US20090076138A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched darunavir
|
US20090076264A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched rivaroxaban
|
US20090076017A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched trabectedin
|
US20090076040A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched valganciclovir
|
US20090076000A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched mycophenolate mofetil
|
US20090075944A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched ibandronate
|
US20090076018A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched ranolazine
|
US20090076164A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched tapentadol
|
US20090076128A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia Llc |
Deuterium-enriched topiramate
|
US20090076157A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched senicapoc
|
US20090076028A1
(en)
*
|
2007-09-15 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched itraconazole
|
US20090076058A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched finasteride
|
US20090118238A1
(en)
*
|
2007-09-17 |
2009-05-07 |
Protia, Llc |
Deuterium-enriched alendronate
|
US20090076154A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched vorinostat
|
US20090076167A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched tramiprosate
|
US20090076126A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched enalapril
|
US20090076027A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched lurasidone
|
US20090076117A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched laropiprant
|
US20090076144A1
(en)
*
|
2007-09-17 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bazedoxifene
|
US20090076127A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched larotaxel
|
US20090076159A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched eplivanserin
|
US20090076011A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched tirapazamine
|
US20090075997A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched satavaptan
|
US20090082334A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched quetiapine
|
US20090082454A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched disufenton
|
US20090082462A1
(en)
*
|
2007-09-25 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched armodafinil
|
US20090082387A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched nvp-bez234
|
US20090082335A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched oxcarbazepine
|
US20090082364A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched levocedtirizine
|
US20090082436A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched rivastigmine
|
US20090082442A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched lubiprostone
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
US20090082471A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched fingolimod
|
US20090082363A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched posaconazole
|
US20090082452A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched lumiracoxib
|
US20090082459A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched guanfacine
|
WO2009051747A1
(en)
*
|
2007-10-15 |
2009-04-23 |
Concert Pharmaceuticals, Inc. |
Deuterated lorcaserin
|
WO2009051782A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
US20090149544A1
(en)
*
|
2007-10-22 |
2009-06-11 |
Concert Pharmaceuticals, Inc. |
Alpha-aminoamide derivatives
|
EP2217548A1
(en)
*
|
2007-10-26 |
2010-08-18 |
Concert Pharmaceuticals Inc. |
Deuterated darunavir
|
US8592487B2
(en)
*
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
WO2009067225A2
(en)
*
|
2007-11-20 |
2009-05-28 |
Concert Pharmaceuticals, Inc. |
Boceprevir derivatives for the treatment of hcv infections
|
ES2396366T3
(es)
*
|
2007-12-10 |
2013-02-21 |
Concert Pharmaceuticals Inc. |
Inhibidores heterocíclicos de quinasas
|
WO2009079637A1
(en)
*
|
2007-12-18 |
2009-06-25 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
WO2009094216A1
(en)
*
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
US8609673B2
(en)
*
|
2008-01-22 |
2013-12-17 |
Concert Pharmaceuticals, Inc. |
Vandetanib derivatives
|
CN101492452B
(zh)
*
|
2008-01-25 |
2010-11-17 |
山东轩竹医药科技有限公司 |
含有二氧杂环庚烷并吡啶的巯基苯并咪唑衍生物
|
CN101492464B
(zh)
*
|
2008-01-25 |
2011-01-12 |
山东轩竹医药科技有限公司 |
含有二氧杂环庚烷并吡啶的巯基咪唑并吡啶衍生物
|
US20090209550A1
(en)
*
|
2008-02-20 |
2009-08-20 |
Auspex Pharmaceuticals, Inc. |
Substituted triazolopyridines
|
MX2010009300A
(es)
|
2008-02-29 |
2010-11-05 |
Concert Pharmaceuticals Inc |
Derivados de xantina substituidos.
|
CA2715036A1
(en)
*
|
2008-03-14 |
2009-09-17 |
Retrotope, Inc. |
Therapies for cancer using isotopically substituted lysine
|
WO2009114814A2
(en)
*
|
2008-03-14 |
2009-09-17 |
Retrotope, Inc. |
Therapeutic substances that modulate genome methylation
|
CN102083801A
(zh)
*
|
2008-03-28 |
2011-06-01 |
康瑟特制药公司 |
喹唑啉衍生物和治疗方法
|
JP2011518783A
(ja)
*
|
2008-04-09 |
2011-06-30 |
コンサート ファーマシューティカルズ インコーポレイテッド |
3−(2−ヒドロキシ−5−メチルフェニル)−n,n−ジイソプロピル−3−フェニルプロピルアミンの誘導体およびその使用方法
|
US8367674B2
(en)
*
|
2008-04-17 |
2013-02-05 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
WO2009145852A1
(en)
*
|
2008-04-17 |
2009-12-03 |
Concert Pharmaceuticals, Inc. |
Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof
|
US20100120786A1
(en)
*
|
2008-04-17 |
2010-05-13 |
Concert Pharmaceuticals, Inc. |
Piperazine Derivatives
|
WO2009146310A1
(en)
*
|
2008-05-28 |
2009-12-03 |
Concert Pharmaceuticals Inc. |
Deuterated tizanidine
|
WO2009154754A2
(en)
|
2008-06-17 |
2009-12-23 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
BRPI0916769A2
(pt)
|
2008-07-15 |
2017-09-26 |
Theracos Inc |
derivados de benzilbenzeno deuterados e métodos de uso
|
US20100093758A1
(en)
*
|
2008-07-23 |
2010-04-15 |
Auspex Pharmaceuticals, Inc. |
Pyridine sulfonamide modulators of endothelin-a receptor
|
US20100221221A1
(en)
*
|
2008-08-12 |
2010-09-02 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
CN102176826B
(zh)
|
2008-08-29 |
2014-08-20 |
康瑟特制药公司 |
取代的三唑并哒嗪衍生物
|
WO2010027448A1
(en)
*
|
2008-09-02 |
2010-03-11 |
Actimis Pharmaceuticals Inc. |
Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
|
AU2009288108B2
(en)
*
|
2008-09-03 |
2013-10-17 |
Teva Pharmaceutical Industries, Ltd. |
2-oxo-1,2-dihydro-quinoline modulators of immune function
|
US20100105755A1
(en)
*
|
2008-09-12 |
2010-04-29 |
Auspex Pharmaceuticals, Inc. |
Substituted benzamide modulators of dopamine receptor
|
US8704001B2
(en)
*
|
2008-09-16 |
2014-04-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
WO2010033270A1
(en)
*
|
2008-09-17 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
ES2402088T3
(es)
|
2008-09-19 |
2013-04-26 |
Concert Pharmaceuticals Inc. |
Compuestos de morfinano
|
US20100087455A1
(en)
*
|
2008-10-06 |
2010-04-08 |
Auspex Pharmaceuticals, Inc. |
Substituted xanthine compounds
|
US8802681B2
(en)
|
2008-10-17 |
2014-08-12 |
Signature Therapeutics, Inc. |
Pharmaceutical compositions with attenuated release of phenolic opioids
|
US20100099701A1
(en)
*
|
2008-10-20 |
2010-04-22 |
Auspex Pharmaceuticals, Inc. |
Isoquinolinone modulators of 5-ht3 receptors
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
US20100137215A1
(en)
*
|
2008-11-25 |
2010-06-03 |
Concert Pharmaceuticals Inc. |
Novel tetrahydro-1h-pyrido[4,3-b]indoles
|
US20100143354A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Auspex Pharmaceuticals, Inc. |
Triazine dna modifiers
|
US20110313004A1
(en)
*
|
2008-12-04 |
2011-12-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyridinones
|
US20100144657A1
(en)
*
|
2008-12-09 |
2010-06-10 |
Auspex Pharmaceuticals, Inc. |
PHENYLPIPERIDINE MODULATORS OF mu-OPIOID RECEPTORS
|
US20100159034A1
(en)
*
|
2008-12-15 |
2010-06-24 |
Auspex Pharmaceuticals, Inc. |
Pyrrolidinone inhibitors of pde-4
|
KR101682427B1
(ko)
*
|
2008-12-23 |
2016-12-05 |
아쿠일루스 파마슈티컬즈, 인코포레이티드 |
통증 및 기타 질병을 치료하기 위한 화합물 및 방법
|
EP2396312A1
(en)
*
|
2009-02-11 |
2011-12-21 |
Celgene Corporation |
Isotopologues of lenalidomide
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
US20110053961A1
(en)
*
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
US8563554B2
(en)
|
2009-03-17 |
2013-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
WO2010118291A2
(en)
*
|
2009-04-10 |
2010-10-14 |
Auspex Pharmaceuticals, Inc. |
Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
|
US20100291151A1
(en)
*
|
2009-04-21 |
2010-11-18 |
Auspex Pharmaceuticals, Inc. |
1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
|
NZ595823A
(en)
|
2009-04-22 |
2014-03-28 |
Axikin Pharmaceuticals Inc |
2,5-disubstituted arylsulfonamide ccr3 antagonists
|
EP2421808B1
(en)
|
2009-04-23 |
2013-07-31 |
Concert Pharmaceuticals Inc. |
4-hydroxybutyric acid analogs
|
WO2010127272A2
(en)
*
|
2009-04-30 |
2010-11-04 |
Concert Pharmaceuticals, Inc. |
Hydroxyethylamino sulfonamide derivatives
|
JP2012526810A
(ja)
|
2009-05-13 |
2012-11-01 |
イントラ−セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
WO2010135579A1
(en)
|
2009-05-22 |
2010-11-25 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
US20120077851A1
(en)
*
|
2009-06-09 |
2012-03-29 |
Medolution Limited |
Urea Derivatives as Kinase Inhibitors
|
ES2469849T3
(es)
|
2009-06-18 |
2014-06-20 |
Concert Pharmaceuticals Inc. |
Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa
|
JP2012531419A
(ja)
|
2009-06-23 |
2012-12-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Gaba−a受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
|
WO2011009075A2
(en)
*
|
2009-07-17 |
2011-01-20 |
Rigel Pharmaceuticals, Inc. |
Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
|
EP2456311A4
(en)
*
|
2009-07-24 |
2013-01-23 |
Concert Pharmaceuticals Inc |
SUBSTITUTED IMIDASOTRIAZINES
|
US8575348B2
(en)
*
|
2009-07-28 |
2013-11-05 |
Auspex Pharmaceuticals, Inc |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
US8637524B2
(en)
*
|
2009-07-28 |
2014-01-28 |
Auspex Pharmaceuticals, Inc |
Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
|
US9512104B2
(en)
|
2009-07-28 |
2016-12-06 |
Auspex Pharmaceuticals, Inc. |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
US8618116B2
(en)
*
|
2009-08-03 |
2013-12-31 |
Daljit Singh Dhanoa |
Deuterium-enriched pyrimidine compounds and derivatives
|
WO2011020044A1
(en)
*
|
2009-08-14 |
2011-02-17 |
Concert Pharmaceuticals, Inc. |
Substituted triazolophthalazine derivatives
|
US8658236B2
(en)
|
2009-08-21 |
2014-02-25 |
Deuteria Beverages, Llc |
Alcoholic compositions having a lowered risk of acetaldehydemia
|
US9260432B2
(en)
|
2009-09-02 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
EP2473052A4
(en)
*
|
2009-09-02 |
2013-03-20 |
Concert Pharmaceuticals Inc |
SUBSTITUTED XANTHINE DERIVATIVES
|
SG179026A1
(en)
|
2009-09-08 |
2012-04-27 |
Signature Therapeutics Inc |
Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
|
EP2483407A2
(en)
|
2009-09-30 |
2012-08-08 |
President and Fellows of Harvard College |
Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
|
WO2011047315A1
(en)
*
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Subsitituted benzimidazoles
|
WO2011056647A1
(en)
*
|
2009-10-28 |
2011-05-12 |
Anadys Pharmaceuticals, Inc. |
Deuterated 5,6-dihydro-1h-pyridin-2-one compounds
|
WO2011060112A1
(en)
|
2009-11-12 |
2011-05-19 |
Osi Pharmaceuticals, Inc. |
Deuterated tyrosine kinase inhibitors
|
WO2011063001A1
(en)
*
|
2009-11-18 |
2011-05-26 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
JP2013511489A
(ja)
*
|
2009-11-21 |
2013-04-04 |
エフ.ホフマン−ラ ロシュ アーゲー |
複素環式抗ウイルス化合物
|
US20110178180A1
(en)
*
|
2010-01-18 |
2011-07-21 |
Kurt Nielsen |
Deuterium-enriched colchicine, thiocolchicine, and derivatives thereof; methods of preparation; and use thereof
|
UY33226A
(es)
*
|
2010-02-19 |
2011-09-30 |
Novartis Ag |
Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6
|
AU2011218805A1
(en)
*
|
2010-02-24 |
2012-08-30 |
Auspex Pharmaceuticals, Inc. |
Trimethoxyphenyl inhibitors of tyrosine kinase
|
CA2790707A1
(en)
*
|
2010-03-01 |
2011-09-09 |
Concert Pharmaceuticals Inc. |
Fluorouracil derivatives
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
EP2542534A1
(en)
*
|
2010-03-02 |
2013-01-09 |
Concert Pharmaceuticals Inc. |
Deuterated tetrahydronaphthalene derivatives
|
US8575221B2
(en)
|
2010-03-17 |
2013-11-05 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
BR112012026768A2
(pt)
*
|
2010-04-21 |
2015-09-29 |
Signature Therapeutics Inc |
composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores.
|
DK2560486T3
(en)
|
2010-04-21 |
2019-02-04 |
Signature Therapeutics Inc |
COMPOSITIONS COMPREHENSIVE ENZYM-TENDABLE AMPHETAMINE PRODRUGS AND ITS INHIBITORS
|
EP2560490A1
(en)
*
|
2010-04-21 |
2013-02-27 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
|
US20110262355A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
|
WO2011133178A1
(en)
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc |
Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
|
WO2012009446A1
(en)
|
2010-07-16 |
2012-01-19 |
Concert Pharmaceuticals Inc. |
Novel pyrimidinecarboxamide derivatives
|
WO2012031073A1
(en)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
US9085788B2
(en)
|
2010-09-01 |
2015-07-21 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
SG188298A1
(en)
*
|
2010-09-03 |
2013-04-30 |
Ivax Int Gmbh |
Deuterated analogs of pridopidine useful as dopaminergic stabilizers
|
WO2012096886A1
(en)
|
2011-01-11 |
2012-07-19 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable oxycodone prodrug
|
JP6016810B2
(ja)
|
2011-01-11 |
2016-10-26 |
シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. |
酵素切断可能なオキシコドンプロドラッグを含んでなる組成物
|
US20130310396A1
(en)
*
|
2011-01-19 |
2013-11-21 |
Hongwen Zhu |
Thiazolidine derivatives and their therapeutic use
|
US8759394B2
(en)
|
2011-02-14 |
2014-06-24 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
US8889687B2
(en)
|
2011-03-04 |
2014-11-18 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
BR112013022946A2
(pt)
|
2011-03-09 |
2017-07-18 |
Signature Therapeutics Inc |
pró-fármacos de agentes ativos com ligantes heterocíclocos
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
US9090585B2
(en)
|
2011-03-28 |
2015-07-28 |
Deuterx, Llc |
2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
|
WO2012151361A1
(en)
*
|
2011-05-03 |
2012-11-08 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
DK2705013T3
(en)
|
2011-05-04 |
2016-07-18 |
Balance Therapeutics Inc |
Pentylenetetrazolderivater
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
CA2860489C
(en)
*
|
2012-02-08 |
2019-11-12 |
Merck Patent Gmbh |
Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor
|
IN2014DN08443A
(xx)
|
2012-04-13 |
2015-05-08 |
Concert Pharmaceuticals Inc |
|
WO2013159026A1
(en)
|
2012-04-20 |
2013-10-24 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
US20150197525A1
(en)
*
|
2012-06-15 |
2015-07-16 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
WO2014008417A1
(en)
|
2012-07-04 |
2014-01-09 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
CA2908929C
(en)
|
2012-07-12 |
2021-01-26 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
CA2879400A1
(en)
|
2012-07-30 |
2014-02-06 |
Concert Pharmaceuticals, Inc. |
Deuterated ibrutinib
|
ES2717279T3
(es)
*
|
2012-08-17 |
2019-06-20 |
Concert Pharmaceuticals Inc |
Baricitinib deuterada
|
US20150210624A1
(en)
*
|
2012-08-22 |
2015-07-30 |
Concert Pharmaceuticals, Inc. |
Deuterated 4-hydroxybutyric acid analogs
|
JP2015531776A
(ja)
|
2012-09-04 |
2015-11-05 |
セルジーン コーポレイション |
3−(5−アミノ−2−メチル−4−オキソキナゾリン−3(4h)−イル)ピペリジン−2,6−ジオンのアイソトポログ及びその製造方法
|
BR112015004959A2
(pt)
*
|
2012-09-07 |
2017-07-04 |
Axikin Pharmaceuticals Inc |
composto isotopicamente enriquecido, composição farmacêutica, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença, distúrbio ou condição mediada por ccr3, relacionada a eosinófilos, relacionada a basófilos, relacionada a mastócitos ou relacionada a mastócitos em um sujeito, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença inflamatória em um sujeito e método para modular a atividade de ccr3.
|
US9643950B2
(en)
|
2012-10-22 |
2017-05-09 |
Concert Pharmaceuticals, Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
|
EP2943489B1
(en)
|
2013-01-09 |
2018-04-11 |
Concert Pharmaceuticals Inc. |
Deuterated momelotinib
|
JP6359563B2
(ja)
|
2013-01-14 |
2018-07-18 |
デュートルクス・リミテッド・ライアビリティ・カンパニーDeuteRx, LLC |
3−(5置換−4−オキソキナゾリン−3(4h)−イル)−3−ジュウテロピペリジン−2,6−ジオン誘導体
|
US20140221369A1
(en)
*
|
2013-02-01 |
2014-08-07 |
Deuterx, Llc |
5-deutero-2,4-thiazolidinedione and 5-deutero-2,4-oxazolidinedione derivatives and compositions comprising and methods of using the same
|
US9801882B2
(en)
|
2013-02-17 |
2017-10-31 |
Intra-Cellular Therapies, Inc. |
Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
|
AU2014236510A1
(en)
|
2013-03-14 |
2015-09-24 |
Deuterx, Llc |
Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
|
CA2941560A1
(en)
|
2013-03-14 |
2014-09-25 |
Deuterx, Llc |
3-(substituted-4-oxo-quinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
|
EP2968268B1
(en)
|
2013-03-15 |
2020-07-29 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
CN103204819B
(zh)
*
|
2013-04-15 |
2015-03-11 |
公安部物证鉴定中心 |
氘代地西泮及其制备方法
|
WO2015031741A1
(en)
|
2013-08-30 |
2015-03-05 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
|
KR102495941B1
(ko)
|
2013-12-03 |
2023-02-06 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
SG11201604519PA
(en)
*
|
2013-12-06 |
2016-07-28 |
Vertex Pharma |
2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
|
US9732031B2
(en)
|
2013-12-20 |
2017-08-15 |
Deuterx, Llc |
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
|
US10188639B2
(en)
|
2014-01-15 |
2019-01-29 |
Deuterx, Llc |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
AU2015209330A1
(en)
*
|
2014-01-27 |
2016-07-28 |
Auspex Pharmaceuticals, Inc. |
Benzoquinoline inhibitors of vesicular monoamine transporter 2
|
KR20160117596A
(ko)
|
2014-02-07 |
2016-10-10 |
오스펙스 파마슈티칼스, 인코포레이티드 |
신규 제약 제제
|
CN106459056A
(zh)
|
2014-02-10 |
2017-02-22 |
康塞特医药品公司 |
经取代的三唑苯二氮卓
|
WO2015154025A1
(en)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
DK3157926T3
(da)
*
|
2014-06-20 |
2019-08-19 |
Intra Cellular Therapies Inc |
Organiske forbindelser
|
US10131671B2
(en)
|
2014-08-07 |
2018-11-20 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US9375408B2
(en)
*
|
2014-09-02 |
2016-06-28 |
Bhupinder Singh |
Methods of making a deuterated or a non-deuterated molecule and pharmaceutical formulations for treatment
|
WO2016069630A1
(en)
|
2014-10-27 |
2016-05-06 |
Concert Pharmaceuticals, Inc. |
Pyrimidine phosphonic acid esters bearing at least one deuterium atom
|
CA2966452A1
(en)
*
|
2014-12-17 |
2016-06-23 |
Samuel David Brown |
Substituted bicyclic compounds as bromodomain inhibitors
|
WO2016123291A1
(en)
|
2015-01-29 |
2016-08-04 |
Signal Pharmaceuticals, Llc |
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
|
CA2981495C
(en)
|
2015-03-31 |
2023-09-26 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated vx-661
|
US10683305B2
(en)
*
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
CN107698620A
(zh)
*
|
2015-06-23 |
2018-02-16 |
江苏天士力帝益药业有限公司 |
一种氘代噻吩并哌啶衍生物、制备方法及其应用
|
JP6595011B2
(ja)
*
|
2015-06-26 |
2019-10-23 |
重▲慶▼迪康▲爾▼▲楽▼制▲薬▼有限公司 |
新規ホスホジエステラーゼ5阻害剤とその使用
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
MA42954A
(fr)
|
2015-09-25 |
2018-08-01 |
Vertex Pharmaceuticals Europe Ltd |
Potentialisateurs cftr deutérés
|
EP3365336B1
(en)
*
|
2015-10-21 |
2023-07-26 |
Neuform Pharmaceuticals, Inc. |
Deuterated compounds for treating hematologic malignancies, and compositions and methods thereof
|
US20200262800A1
(en)
*
|
2015-11-16 |
2020-08-20 |
Ptc Therapeutics, Inc. |
Hydrogen isotope-enriched analogues of 1,2,4-oxadiazole benzoic acid compounds, compositions and uses thereof
|
US11267777B2
(en)
|
2015-11-19 |
2022-03-08 |
Concert Pharmaceuticals, Inc. |
Deuterated EPI-743
|
AU2017211791B2
(en)
|
2016-01-26 |
2022-01-06 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US10519193B2
(en)
*
|
2016-02-02 |
2019-12-31 |
Shenzhen Targetrx, Inc. |
Steroidal compound, composition containing the same and use thereof
|
EP3416629A4
(en)
|
2016-02-16 |
2019-08-07 |
CoNCERT Pharmaceuticals, Inc. |
DEUTERATED GFT-505
|
DK3407889T3
(da)
|
2016-03-25 |
2021-08-09 |
Intra Cellular Therapies Inc |
Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
JP6987868B2
(ja)
|
2016-12-29 |
2022-01-05 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
有機化合物
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
WO2018175969A1
(en)
|
2017-03-24 |
2018-09-27 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
EP3625214B1
(en)
*
|
2017-05-16 |
2022-07-06 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
CN109498811A
(zh)
*
|
2017-09-15 |
2019-03-22 |
江苏吉贝尔药业股份有限公司 |
一种含钾离子竞争性酸阻滞剂和非甾体抗炎药的复方制剂
|
BR112020010156A2
(pt)
|
2017-11-22 |
2020-11-10 |
Concert Pharmaceuticals, Inc. |
análogos deuterados de d-serina e usos dos mesmos
|
BR112020010335A2
(pt)
|
2017-12-01 |
2020-11-10 |
Vertex Pharmaceuticals Incorporated |
processos para produzir moduladores de regulador de condutância de transmembrana de fibrose cística
|
WO2019120194A1
(zh)
*
|
2017-12-22 |
2019-06-27 |
深圳市塔吉瑞生物医药有限公司 |
一种取代的吡唑并[1,5-a]嘧啶化合物及其药物组合物及用途
|
WO2019144885A1
(zh)
|
2018-01-23 |
2019-08-01 |
深圳市塔吉瑞生物医药有限公司 |
取代的吡唑并[1,5-a]嘧啶类的大环化合物
|
JP7401442B2
(ja)
|
2018-01-31 |
2023-12-19 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規使用
|
CN109970745B
(zh)
*
|
2018-04-16 |
2020-12-08 |
深圳市塔吉瑞生物医药有限公司 |
取代的吡咯并三嗪类化合物及其药物组合物及其用途
|
US11684622B2
(en)
*
|
2018-06-19 |
2023-06-27 |
Celecor Therapeutics, Inc. |
Deuterated RUC-4
|
JP7262843B2
(ja)
*
|
2018-07-12 |
2023-04-24 |
深▲チェン▼市塔吉瑞生物医薬有限公司 |
ジアリールピラゾール化合物、該化合物を含む組成物およびその使用
|
EP3843738A4
(en)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NEW METHODS
|
EP3843739A4
(en)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NEW METHODS
|
CN111116492B
(zh)
*
|
2019-01-25 |
2021-07-09 |
青岛吉澳医药科技有限公司 |
氘代苯甲氨嘧啶二酮衍生物及其用途
|
CN110194773B
(zh)
*
|
2019-07-26 |
2019-11-22 |
上海美迪西生物医药股份有限公司 |
吡咯并吡唑类衍生物、其制备方法及其在医药上的应用
|
US11767317B1
(en)
|
2020-06-30 |
2023-09-26 |
Poxel Sa |
Methods of synthesizing enantiopure deuterium-enriched pioglitazone
|
US11319313B2
(en)
|
2020-06-30 |
2022-05-03 |
Poxel Sa |
Crystalline forms of deuterium-enriched pioglitazone
|
US20230150965A1
(en)
*
|
2021-11-05 |
2023-05-18 |
Terran Biosciences, Inc. |
Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereof
|
US20230202998A1
(en)
|
2021-11-17 |
2023-06-29 |
Terran Biosciences, Inc. |
Phenethylamine compounds salts, polymorphic forms and methods of use thereof
|
CN116726011A
(zh)
*
|
2022-03-04 |
2023-09-12 |
丽珠医药集团股份有限公司 |
艾普拉唑用于调节消化道微生态的用途
|